ABSTRACT Eight out of 35 human intracranial tumors were shown by restriction enzyme analysis to contain unintegrated simian virus 40 (SV40) DNA molecules. The relative amount of viral DNA was estimated to be the equivalent of one viral genome within every 10th to 20th cell. No infectious virus was detected in tissue cultures established from the tumors. From only one tumor was it possible to rescue, by cell fusion, infectious SV40 displaying wild-type properties. In those cases that permitted a more detailed analysis, the restriction enzyme cleavage patterns appeared to correspond to the wild-type patterns with one exception, in which the SV40 episomes displayed a deletion of approximately 70 base pairs close to the origin of DNA replication. From one tumor, the SV40 genomes were transferred into permissive CV-1 monkey cells by transfection with the total tumor DNA. Despite their persistence as episomes no infectious virus was produced. Furthermore, no viral antigens were detectable, although the SV40 messengers for the small and the large tumor antigens were present. These cells had, however, acquired the ability to form colonies in low concentrations of serum. Thus this report provides, by restriction enzyme analysis, direct evidence for the presence of SV40 DNA in human tumors.
The search for simian virus 40 (SV40) genomes in human tumors is motivated by a number of reasons. Together with poliovirus vaccine, SV40 had been administered inadvertently to several million people about 20 years ago (1). Furthermore, volunteers had then been given SV40 by a respiratory route (2) . It was only later that the oncogenic potential of SV40 was appreciated. It was shown that SV40 together with other closely related papovaviruses isolated from human patients such as JC and BK, which all share base sequence homologies (3, 4) , are capable of transforming cells in vitro (5) (6) (7) and of inducing brain tumors in newborn hamsters (8, 9) . Furthermore, JC virus has been shown to be capable of inducing brain tumors in owl monkeys (10) .
It has been reported that these papovaviruses might be associated with human tumors because the SV40 tumor antigen (T antigen), with which BK-, JC-, and PML-induced T antigens crossreact (11) , was found with the immunofluorescence technique in human melanoma metastases (12) and in tissue culture cells derived from human meningiomas (13, 14) . In these reports, however, evidence for the presence of viral DNA sequences in the tumor cells was not provided. Other authors have recovered SV40 virions from human brain tumors (15, 16) by passaging the isolates through permissive tissue culture cells. This does not entirely rule out possible contaminations or alterations ofthe genetic constitution ofthe viral genomes derived from the tumors. More direct evidence was provided by DNA-DNA reassociation kinetic experiments showing the presence ofSV40-related DNA sequences in at least one out of every seven human brain tumors (17) . Although stringent, the DNA-DNA liquid hybridization method (18) does not provide conclusive evidence for the presence of the entire SV40 genome.
The following report furnishes evidence for the presence of SV40 genomes in human brain tumors by restriction enzyme analysis. The viral genomes exist in the tumors as episomal molecules, which can be transferred to recipient permissive cells by transfection. They are perpetuated as episomes that do not give rise to infectious viral progeny, thus displaying unusual biological properties.
MATERIALS AND METHODS
Tumors and Cells. Tumor biopsy materials (designated with letters) were obtained from the Neurochirurgische Klinik, Universitat Heidelberg. The autopsy material (meninges) was provided by the Institut fur Neuropathologie, Universitat Heidelberg. Immediately upon receipt, primary cell cultures (passage 0) were established and the remainder of the tumors was frozen in several portions at -700C. Tumors and tissue cultures designated with numbers were provided by the Institute for Human Genetics, University of the Saar, which is not concerned with work on SV40. Flow 3000 cells, a permanent line of human brain cells, were purchased from Flow Laboratories (Bonn, Federal Republic ofGermany). Flow 3000, CV-1 African green monkey kidney cells, and SV40-transformed 3T3 (SV3T3) mouse cells were grown in Eagle's medium containing 10% fetal calfserum with 2 times the concentration of Earle's amino acids and vitamins. The tumor cell cultures were grown in the same medium.
Isolation of DNA. The DNA was extracted from the tumors and from cells according to the method of Gross-Bellard et aL (19) . At least two independent extractions were performed, using different batches of reagents.
Restriction Endonucleases. The restriction endonucleases were purchased from Bethesda Research Laboratories (Rockville, MD). Samples were included in each slab gel after mixture with either CV-1 or Flow 3000 DNA to monitor the presence ofputative contaminating SV40 DNA sequences within the enzyme batches.
Agarose Gel Electrophoresis. Electrophoresis in 1.4% agarose (SeaKem, Marine Colloids, Rockland, ME) was performed as described (20 and hybridization were essentially as described (21) .-The filters were preincubated at 670C in 5 times the concentration of Denhardt's solution (22) . Hybridization mixtures (15 ml) contained HeLa cell DNA at 50 ,g/ml and 1 X 106 cpm/ml ofcloned nicktranslated SV40 [32P]DNA (2 X 108 cpm/,g). Hybridization reactions were performed for 72 hr at 680C in 5 times the concentration of Denhardt's solution and 6 times the concentration of standard saline/citrate buffer.
The SV40-specific RNA species were revealed by the technique described recently by Thomas (23) .
Cell Fusion. Fusion experiments were performed as described (24) by mixing either CV-1 or Flow 3000 cells with tumor cells at 2:1 to 4:1 ratios. The cells were suspended in 1 ml of40% (wt/vol) polyethyleneglycol 6000, on coverslips, and supplied with fresh medium at weekly intervals. The cultures were passaged, on the average, every 10 days (1:4 split ratios).
Antisera. Anti-SV40 serum, raised in rabbits, precipitated the large T antigens (25) as well as the VP 1 and VP 3 capsid antigens. SV40 anti-T serum obtained from tumor-bearing hamsters precipitated both the Mr 92,000 T antigen and the Mr 17,000 T antigen.
Immunofluorescence. Cells were fixed in acetone and allowed to react either directly with anti-SV40 serum or indirectly with two serum preparations from tumor-bearing hamsters.
Transfection. Tumor DNA was administered to CV-1 cells as described (26) , using CV-1 DNA for mock transfections.
RESULTS
Identification of SV40 DNA Sequences by the Filter Hybridization Method of Southern. The most sensitive technique for detection of either free or integrated tumor virus DNA sequences is the Southern method (21). The equivalent of one SV40 genome can be revealed, when present, within every 10th to 20th cell (Fig. 1, tracks a-d) .
The DNA from various human brain tumors (for a complete list see Table 1 ) was probed after restriction enzyme digestion with nick-translated SV40 [32P]DNA. Eight out of35 specimens contained sequences homologous to SV40 DNA. The intensity of the bands, however, was low, being in most cases almost at the threshold of detectability (Fig. 1) . A comparison with the authentic SV40-specific bands representing unit-length linear Fo III DNA in tracks a-d revealed that on the average only every 10th cell contained homologous sequences. There were only a few exceptions-namely, a tumor tissue culture T 2095 and the tumor ED-in which we noticed relatively higher amounts of SV40 DNA. With a few exceptions, multiple-cut endonuclease cleavage products escaped detection owing to their small size.
The analysis of the DNA from the meningioma biopsy, designated AW, from a 26-year-old female patient led after cleavage with Pst I to the detection oftwo fragments (Fig. 1 , track f) equal in size to the authentic SV40 DNA fragments in track e. The DNA, extracted from another portion of the same tumor, was digested with EcoRI. As shown in Fig. 1 track g, one band was generated that comigrated with wild-type SV40 Fo III DNA of unit length. These observations permit the conclusion that free SV40 DNA of wild-type size was present within the tumor, which contained at least the appropriately positioned recognition sequences for the Pst I endonuclease. No "off-size" bands comigrating with high molecular weight host DNA fragments, indicative ofcovalent linkage between viral and host DNA, were discernible.
Another meningioma, designated HCS (tracks h and i), and a medulloblastoma (SAR, track j) contained DNA homologous with SV40 DNA. In both cases we were unable, owing to the 14 days, except for tracks e and m, which were exposed for 2 days. Purification and restriction enzyme digestion of the tumor and control tissue DNA were performed in a laboratory not concerned with work on SV40, using the glassware and the reagents of this laboratory. Furthermore, the tumors were divided immediately upon receipt into at least two portions, the DNA of which was isolated and investigated on several independent occasions to confirm either the presence or the absence of viral DNA sequences in a small amounts ofmaterial available, to provide additional cleavage patterns. In the uncleaved HCS sample only one band was detected, which comigrated with SV40 Fo I DNA (track h). After digestion with the single-cut endonucleases EcoRI (Fig.  1 , track i) and Hpa II (Fig. 1, track j) , one band of Fo III unitlength DNA was generated in each sample. This observation, although not conclusive, is compatible with the assumption, that, as in the case of AW viral DNA, sequences were present in both specimens in a free, unintegrated state. The use of the no-cut enzyme Xba I revealed SV40 episomes in the tumor T 2106, which contained circular SV40 DNA (Fo I and II) and some Fo III. Digestion with Hpa II led to the appearance ofFo III (Fig. 1, track 1) .
The DNA-from apparently normal autopsy material (four different meninges were examined), when probed with SV40
[32P]DNA, was found to be devoid of detectable homologous sequences (Fig. 1, track k) .
Only a few tumors happened to contain viral DNA in large enough amounts to permit a more detailed analysis. One such case, an astrocytoma designated ED (Table 1) was derived from biopsy material from a 10-year-old child. The uncleaved tumor DNA, when hybridized with 32P-labeled SV40 DNA, showed a hybridization signal (Fig. 2, track b) at the position of marker SV40 Fo I (Fig. 2, track a) . Application of the no-cut enzyme Bgl II also revealed Fo I (Fig. 2, track c) , whereas the singlecut endonuclease Taq I generated unit-length Fo III (Fig. 2 track d). After cleavage with the endonuclease Hpa I, three fragments appeared (Fig. 2 , track e) that comigrated with the authentic wild-type SV40 DNA fragments (Fig. 2, track f) . These data show the existence of episomal SV40 DNA displaying a wild-type cleavage pattern in the tumor ED.
A more detailed investigation was possible in tissue culture cells that were established from the meningioma T 2095. The DNA extracted after digestion with the no-cut enzyme Sma I revealed bands comigrating with SV40 Fo III and Fo II (Fig.  3, track a) . Authentic wild-type SV40 DNA markers (Fo III and some Fo I) are contained in track ffor comparison. The enzyme Pst I produced two bands (Fig. 3, track b) , the sizes of which were identical to the wild-type fragments in Fig. 3, track Parallel cultures at a similar passage level of T 2095 contained relatively more SV40 DNA, as may be deduced from the increased intensity of the Fo III and Fo II bands in track d, in which the no-cut enzyme Xba I had been used. Unlike Bgl II, this enzyme preparation (as well as Xba I) contained contaminating endonucleases that introduced nicks into the circular DNA to the extent that eventually Fo III was generated. Most interestingly, the pattern obtained after digestion with HindIII (Fig. 3, track e) clearly disclosed a deletion of the episomal SV40 DNA in the HindIll C fragment, which was found to be smaller (by approximately 70 base pairs) than the corresponding wild-type fragment (Fig. 3, track f) . This result is corroborated by the data obtained after digestion of the T 2095 DNA with Ava II (Fig. 3, track g ). The region spanned on the physical SV40 map by the HindIII C fragment contains nearly all the sequences in the Ava II D fragment. Accordingly, the fragment Ava II D migrated faster than the corresponding wildtype fragment (Fig. 3, track h) Fusion of tumor cells with permissive CV-1 cells or with the human brain cell line Flow 3000 failed to induce infectious virus or the expression of SV40 antigens with but one exception: 5 weeks after fusion of AW cells with Flow 3000 cells, infectious SV40 was recovered that displayed wild-type properties regarding the restriction enzyme cleavage pattern of its DNA, induced viral proteins, and its transforming ability. In view of this single case, the induction of SV40 virions appears to be the exception rather than the rule.
Transfection with Tumor DNA. In order to assess the biological properties ofthe SV40 episomes in human brain tumors, transfection experiments were performed with permissive CV-1 cells as recipients. The DNA from the oligodendroglioma T 2106, of which significant amounts were available and which appeared to contain the largest number of SV40 genomes, was employed. After six passages after transfection a clonal line was established nonselectively; this line, together with the uncloned culture, was monitored during various further passages for the presence of SV40-induced antigens and for infectious virus. Although neither SV40 antigens nor virus was detected, the Southern blot analysis revealed the persistence of episomal SV40 genomes with wild-type cleavage patterns (Fig. 4) in the cloned and uncloned cultures. The transfection was repeated three times with T 2106 DNA, each time with persistence of apparently unexpressed SV40 episomes. It is of particular interest that the SV40 episomes were, nevertheless, transcribed into two RNA species that were equal in size to both T antigen messengers in SV40-transformed cells (Fig. 5) .
This raises the question ofthe permissivity ofthe transfected CV-1 cells. Superinfection with wild-type SV40 at a multiplicity of 0.2 plaque-forming units per cell caused, owing to virus replication, complete lysis of the cloned episome-containing cells, thereby implying that the aberrant biological behavior is due to the episomal SV40 genomes rather than to the host cells.
The important question ofwhether a transformed phenotype is being conveyed to the recipient cells cannot be answered unequivocally at present. Both the cloned and uncloned transfected CV-1 cells readily formed colonies in medium supplemented with only 0.5% fetal calf serum (mock-transfected CV-1 cells failed to grow) when tested after many (14) passages. The (27) . cells changed to an epitheliod shape and they attained higher saturation densities than mock-transfected CV-1 cells. The acquisition ofthe transformed phenotype has been observed after three independent transfection experiments with T 2106 DNA. On the other hand, in a subsequent transfection experiment the cells failed to grow in low serum concentrations despite the presence of SV40 episomes. Whether this could be due to the lower passage level (4) in this particular case, at which the transformed phenotype may not yet have been established, remains to be seen.
DISCUSSION
We have revealed, in this report, that almost one-quarter ofthe investigated tumor specimens contained SV40. DNA. One possibility is that SV40 is being carried merely as a passenger and as such is irrelevant in the pathogenesis of these tumors. The fact that SV40 DNA was detected in 8 out of 35 tumors makes us reluctant to totally dismiss its having an etiologic role, although there are a number of points that are difficult to reconcile with a viral etiology.
First, the physical state of the viral genomes-unintegrated episomal structures-deserves to he dealt with. In general, transformation of cells by tumor viruses appears to be brought about by integration of the viral genomes (or at least the viral oncogenes) into the host cell genome. In contrast, there is evidence for the presence ofexclusively unintegrated papovavirus genomes, both in human brain cells transformed by BK virus (28) (29) . Episomal genomes have also been observed ini experimentally induced tumors after infection with BK virus (30, 31) and in naturally occurring tumors (32, 33) of which BPV seems to be the etiological agent.
Hence, formation of tumors can be induced without the involvement of linkage between papovavirus and host cell genomes.
Absence of integration may lead to loss of viral genomes by segregation, provided the replication of the viral DNA is under control of the host cell as in the case ofthe latent HD virus (34) . It is conceivable that the unequal distribution of SV40 genomes within the tumors (on the average only one viral genome within every tenth cell) may have been due to such host cell control mechanisms.
One is tempted to reject the papovavirus etiology of human tumors bearing viral DNA sequences for two further reasons: (i) absence ofviral genomes from the majority ofthe tumor cells, and (ii) apparent lack of expression of viral tumor antigens. The observation mentioned first poses, indeed, the greatest obstacle. Mechanisms hitherto unnoticed would have to be invoked to account for a viral etiology; for example, the induction of the transformed phenotype by transfer of viral oncogene products to cells lacking the viral oncogene. This possibility can, in our opinion, not be excluded a priori.
The failure to reveal viral T antigens in transformed and in malignant cells is, on the other hand, not unprecedented. BK virus-transformed clones of human brain cells, although being devoid of demonstrable T antigen, were capable of inducing tumors in animals (28) .
It has not been the purpose ofthis work to pursue the possible routes by which the patients might have come into contact with SV40. Participation in the vaccination program, for example, does not appear to have been a prerequisite, because one 54-year-old patient (T 2106) did not take part, and one patient's (ED) age (10 years) excludes the contact with the SV40-containing vaccines.
The SV40 episomal DNA in human brain tumors differs from wild-type SV40 in a number of ways. First of all, with but one exception they failed to give rise to infectious viral progeny either after fusion with or after transfection into permissive cells. In no cases were late SV40 functions (capsid antigens) expressed. Furthermore, a rather unusual property was discovered, which to our knowledge is unprecedented: after transfection of T 2106 DNA into permissive CV-1 cells only messengers for both the large and the small SV40 T antigens were present, whereas late messengers were missing despite the permissive environment. The absence of the late messengers and their translation products strongly suggests that the episomes bear mutations in control regions that regulate late transcription. This feature would render such genomes, which are not associated with recognizable viral capsid antigens, inaccessible to immunological defense mechanisms of the body. Also, the failure to induce infectious virus can be readily explained by such defects. One may speculate that mutants of this type could inapparently occur also in laboratory SV40 strains, where they are outgrown by the vast majority of wild-type genomes.
It may be possible to amplify episomal SV40 genomes from brain tumors by molecular cloning in order to assess whether they indeed, bear, particular mutations in regions affecting late transcription. We feel, that with the aid of such amplified genomes, some of the immediate above-mentioned questions can perhaps be answered. Then, further questions relevant to the important problem of a viral etiology of the brain tumors can be more competently pursued.
